BGM
OLMA icon

Burkehill Global Management’s Olema Pharmaceuticals OLMA Stock Holding History

Burkehill Global Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.86M Hold
125,000
– – 0.09% 128
2025
Q4 		$3.13M Buy
+125,000
New +$2.22M 0.21% 98

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Burkehill Global Management's OLMA Position: Q1 2026 in Review

Burkehill Global Management held its Olema Pharmaceuticals (OLMA) position steady in Q1 2026 at 125,000 shares worth $1.86M. The position accounts for 0.09% of the portfolio, ranked #128.

Burkehill Global Management first reported a position in OLMA in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.13M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Burkehill Global Management held 125,000 shares of Olema Pharmaceuticals worth $1.86M as of Q1 2026.
  • Burkehill Global Management left its Olema Pharmaceuticals share count unchanged in Q1 2026.
  • Olema Pharmaceuticals made up 0.09% of Burkehill Global Management's portfolio in Q1 2026, its #128 holding.
  • Burkehill Global Management first reported a position in Olema Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Burkehill Global Management's Olema Pharmaceuticals position peaked at $3.13M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Burkehill Global Management's 13F filing for Q1 2026, filed 15 May 2026.